Wednesday | October 12, 2022 | 12:00-12:30 pm ET
The 340B Drug Pricing Program is meant to provide patients in need or patients in lower income areas with access to prescription drugs at significantly discounted prices. The current structure of the 340B program allows hospitals to reap massive profits by purchasing drugs at a discount, then keeping those profits instead of passing them on to the patients who need them.
Join Rose Gerber and her guests Ted Okon, Executive Director and Nicolas Ferreyros, Managing Director, Policy, Advocacy & Communications, on Wednesday, October 12, 2022 at 12 p.m. ET, for a discussion about this federal program gone awry.
Ways to register: